Speakers
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center, United States
Sonia Appel, Founder and Principal, Alismere, United States
Aniket Badkar, Director, Formulation and Drug Product Development, Vir Biotechnology, Inc., United States
Julio Baez, Bioengineering Industrial Advisor, University of California San Diego, United States
Jason Beckwith, Professor, University of Dundee, United Kingdom
Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics, Puerto Rico
Prasun Chakraborty, CEO and Founder, Genevation LTD, United Kingdom
Xiaocheng Chen, Vice President, Antibody Therapeutics, Virtuoso Therapeutics, United States
David Chen, Senior Director, Pharmacy Operations, Clinical Utilization and Intelligence, The Permanente Medical Group Inc, United States
Qiang Chen, Professor, Biodesign Institute at Arizona State University, United States
Brandon DeKosky, Associate Professor, Massachusetts Institute of Technology / The Ragon Institute, United States
Vaibhav Deokar, Principal Scientist, LUPIN LIMITED, India
Andrew DiChiara, Senior Scientist II, AbbVie, United States
Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc., United States
Hana Do, Research Analyst, Tufts Center for the Study of Drug Development, United States
Anselm Ebert, Business Development Director, H and T Presspart Manufacturing, Germany
Kamal Egodage, Founder and President, Lasanth Consulting, United States
Wendy Epstein, Professor of Law and Associate Dean of Research and Faculty Developmen, Depaul University College Of Law, United States
Ugur Eskiocak, CEO, Voro Therapeutics, Inc, United States
Mourad Farouk Rezk, Global Head Of Medical And Development, Biosimilars, Biogen, Switzerland
Gordon Freeman, Researcher, Dana Farber Cancer Institute, United States
Jorge García, CEO and Founder, Patagonia Healthcare, United States
Marvin Gee, VP, Head of Research, 3T Biosciences, United States
Huub Gelderblom, Director, Fred Hutch, United States
Scott Greilach, Senior Research Scientist, Immunis Inc., United States
Rajarsi Gupta, Assistant Professor, Stony Brook Medicine, United States
Ana Isabel Gutiérrez López, Global Business Development Manager, H and T Presspart Manufacturing, Spain
Tzvika Hartman, SVP Computation, Biolojic Design, Israel
Net Haskins, Scientist II, Protein Engineering, Amgen, United States
Sophia Humphreys, Executive Director, System Pharmacy, Sutter Health, United States
Clayton Irvine, Senior Manager, Oncology Cancer Care, Mayo Clinic, United States
Zoran Krunic, Sr. Manager Data Science, Amgen, United States
Keiichiro Kushiro, Director of Research, Mucommune, United States
Jin Lee, Founder, IMIDeology, United States
isabelle lehoux, director, Gilead Sciences, United States
Sabrina Leslie, Associate Professor, The University of British Columbia, Canada
Matteo Levisetti, Chief Medical Officer, Cue Biopharma, INC, United States
Mengyue (J.P.) Li, Co-Chairman, Meridian Universal Health Group Inc. / Wharton Alumni Angels, United States
Cate Lockhart, Executive Director, Biologics and Biosimilars Collective Intelligence Consortium, United States
Mark Mamula, Professor Of Medicine Rheumatology, Yale University, United States
Jay Mandrekar, Professor Of Biostatistics And Neurology, Mayo Clinic, United States
Cheryl Marcotte, Clinical Quality leader, GSK, United States
Amy Margolies, Founder / CEO, Sunshine Theory, United States
Nicholas Marshall, Director of Protein Sciences, Invenra Inc, United States
Shamekka Marty, Patient Advocate, National Minority Health Association, United States
Ivan Mascanfroni, Senior Director, Immunology, Seismic Therapeutic, United States
Chris Mason, Professor, Cell & Gene Therapy, University College London, United Kingdom
Santosh Misal, Scientist, National Institutes of Health, United States
Liviu Movileanu, Professor, Department Of Physics, Syracuse University, United States
Savita Nair, Associate Director, Sangamo Therapeutics, United States
William Paseman, Founder, rarekidneycancer.org, United States
Hetal Patel, Vice President, Medical Affairs, Celltrion Healthcare, United States
Salome Philip, CMC Project Manager, Attralus, United States
Chayne Piscitelli, Principal Scientist, Protein Engineering, Zymeworks, Canada
Kamal Puri, CSO, OncoResponse, United States
Steve Quayle, VP Research Biology & Translational Medicine, Cue Biopharma, United States
Udaya Rangaswamy, Director of Translational Biology, Rondo Therapeutics, United States
Volker Schellenberger, SVP Research Oncology, Vir Biotechnology, Inc., United States
Jan Schnitzer, Director, P.R.I.S.M., United States
Alessandro Sette, Professor, La Jolla Institute for Allergy and Immunology, United States
Adeleh Taghi Khani, Senior Scientist II, Quest Diagnostics, United States
Keenan Taylor, Principal Research Scientist I, Abbvie, United States
Andy Tedeschi, Vice President, Market Access and Account Management, Organon, United States
Andrew Tsourkas, Bioengineering Professor, University of Pennsylvania, United States
Ariadne Tuckmantel Bido, Senior Scientist, ScopeSys, Canada
Hans Van Der Vliet, Chief Scientific Officer, LAVA Therapeutics, Netherlands
Jyothsna Visweswaraiah, Director, Biotherapeutics, Drug Creation, Seismic Therapeutic, United States
Christine Von Raesfeld, Board member/advocate, The Light Collective, United States
Kim Walker, Faculty Director & Graduate Advisor Center for Regulatory Science, San Diego State University, United States
Xi Zhao, Head, Oncology Bioinformatics, Research and Development, AbbVie, United States
Yue Zhao, Principal Scientist, Genentech, United States
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events